Scott Randal W.
BridgeBio Pharma, Inc. - Common Stock · Director
Scott Randal W. is listed in filings as Director at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Jun 24, 2025 to May 19, 2026. Reported amounts are shown as $413.5K to $141.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $413k6.2k shares | SellMay 15, 2026 | $66.69 | $81.46 | |
| $141k2.1k shares | SellMay 15, 2026 | $67.53 | $81.46 | |
| $103k1.5k shares | SellMay 15, 2026 | $68.23 | $81.46 | |
| $14k200 shares | SellMay 15, 2026 | $69.12 | $81.46 |